Operating Segment Information (Tables)

12 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, for the years ended September 30, as follows (in thousands):

	2014			2013			2012
Revenue:
Medical Device	$	43,068		$	41,153		$	37,883
In Vitro Diagnostics		14,371			14,979			14,045
Total revenue	$	57,439		$	56,132		$	51,928
Operating income (loss):
Medical Device	$	22,636		$	21,164		$	18,431
In Vitro Diagnostics		3,459			4,222			4,542
Total segment operating income		26,095			25,386			22,973
Corporate		(7,519	)		(6,566	)		(6,631	)
Total operating income from continuing operations	$	18,576		$	18,820		$	16,342
Depreciation and amortization:
Medical Device	$	1,136		$	1,255		$	1,414
In Vitro Diagnostics		850			864			774
Corporate		729			767			741
Total depreciation and amortization	$	2,715		$	2,886		$	2,929

Revenue from Major Customers

Revenue from customers that equaled or exceeded 10% of total revenue was as follows for the years ended September 30:

	2014			2013			2012
Medtronic		19	%		19	%		19	%

Geographic Revenue

Geographic revenue was as follows for the years ended September 30:

	2014			2013			2012
Domestic		78	%		79	%		79	%
Foreign		22	%		21	%		21	%